Medtech InsightRestor3d has agreed to pay approximately $17m to acquire Conformis , its competitor in the 3D-printed orthopedics market. It will purchase all outstanding common stock shares of Conformis at a price
Medtech InsightDeals In September BI, Inflammasome Ally In $160m Retinal Diseases Collaboration Boehringer Ingelheim International GmbH and Inflammasome Therapeutics Inc. agreed to co-develop up to three candida
Medtech InsightFact or fantasy? The bioprinting of a human organ. For many, it is the holy grail of health care, beginning with establishing cellular function, which is already a reality. Cellular function would be
In VivoIN VITRO DIAGNOSTICS Financings HTG Molecular Diagnostics Inc. HTG Molecular Diagnostics Inc. netted $37.9mm through a public offering of 13.9mm common shares (including the overallotment) at $2.9